Reckitt Benckiser Group
RB/ LN
/
UK
Suboxone hazards
|
|
Price (p)
3,376
Market Cap (£M)
24,473
|
|
Perf. 1W:
|
1.75 %
|
|
Perf. 1M:
|
8.66 %
|
|
Perf. 3M:
|
7.48 %
|
|
Perf Ytd:
|
0.60 %
|
RB is a leader in the household and personal care (HPC) market. Its strategy aims to enhance the market position of its 18 major br...
Read More
Operating profit growth is driven by the household and health & personal care division (89% of sales, 76% of operating profit), con...
Read More
We give RB a premium of 15% for P/E, thanks to its stronger growth and its positioning in the OTC market; a premium of 20% for E...
Read More
Analyst: Armelle Moulin
Business concepts
-
Brand name
-
CF funded capacity exp...
-
Structural growth
Investment Concepts
-
Acquisition based growth
-
Free cash flow story
-
One share, no vote
|
© 2010, AlphaValue All rights reserved.
This publication is strictly for subscriber’s own, non-commercial, internal use. No part of it may be reproduced, resold, stored or transmitted in any printed, electronic or other form, or used for generating or marketing any printed or electronic publication, service or product.